HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.

AbstractCONTEXT:
Mouse studies suggest that adropin, a peptide hormone, is required for metabolic homeostasis and prevention of obesity-associated insulin resistance. Whether obesity and insulin resistance are associated with low plasma adropin levels in humans is not known.
OBJECTIVES:
Our objective was to investigate the hypothesis that obesity and indicators of insulin resistance are associated with low adropin levels and determine whether weight loss regulates adropin levels.
DESIGN AND PARTICIPANTS:
Plasma was obtained from 85 female [age 21-67 yr, body mass index (BMI) 19.4-71.5 kg/m2] and 45 male (age 18-70 yr, BMI 19.1-62.6 kg/m2) volunteers for other clinical studies. The impact of Roux-en-Y gastric bypass was investigated in 19 obese females (BMI 37-65 kg/m2) using samples collected at baseline and 1-12 months after surgery.
RESULTS:
Adropin levels correlate negatively with BMI (r=-0.335, P<0.001) and age (r=-0.263, P=0.003). Age-adjusted adropin levels are higher in males [4.1 ng/ml; 95% confidence interval (CI)=3.6-4.6 ng/ml] than females (3.0 ng/ml; 95% CI=2.6-3.4 ng/ml) (P=0.001). In all subjects, lower age-adjusted adropin levels were observed in overweight (3.3 ng/ml; 95% CI=2.8-3.8 ng/ml, P=0.033) and obese (2.7 ng/ml; 95% CI=2.1-3.3 ng/ml, P=0.001) compared with healthy-weight subjects (4.1 ng/ml; 95% CI=3.6-4.5 ng/ml). This effect was gender specific (weight category×gender, P<0.001) and was observed in males only. Aging and diagnosis with two or more metabolic syndrome risk factors was associated with low adropin levels, irrespective of sex. Adropin concentrations increased after Roux-en-Y gastric bypass, peaking 3 months after surgery (P<0.01).
CONCLUSIONS:
Although males exhibit higher adropin levels that are reduced by obesity, aging and markers of insulin resistance are associated with low plasma adropin irrespective of sex.
AuthorsAndrew A Butler, Charmaine S Tam, Kimber L Stanhope, Bruce M Wolfe, Mohamed R Ali, Majella O'Keeffe, Marie-Pierre St-Onge, Eric Ravussin, Peter J Havel
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 97 Issue 10 Pg. 3783-91 (Oct 2012) ISSN: 1945-7197 [Electronic] United States
PMID22872690 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Proteins
  • Enho protein, human
  • Intercellular Signaling Peptides and Proteins
  • Peptides
Topics
  • Adolescent
  • Adult
  • Aged
  • Aging (metabolism)
  • Blood Proteins (metabolism)
  • Dyslipidemias (epidemiology, metabolism)
  • Female
  • Gastric Bypass
  • Homeostasis (physiology)
  • Humans
  • Insulin Resistance (physiology)
  • Intercellular Signaling Peptides and Proteins
  • Male
  • Metabolic Diseases (epidemiology, metabolism)
  • Middle Aged
  • Obesity (epidemiology, metabolism, surgery)
  • Peptides
  • Postoperative Period
  • Risk Factors
  • Sex Distribution
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: